mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.02 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
-0.38 |
0.02 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.03 |